Organization
Department of Oncology centre Clifford Hospital
1 abstract
Abstract
A multicenter phase I/II trial of induction chemotherapy followed by camrelizumab, apatinib, plus chemotherapy as first-line treatment for extensive-stage small-cell lung cancer.Org: Pulmonary and Critical Care Medicine, Guangzhou Institute of Respiratory Health, Guangzhou Institute of Respiratory Health, National Center for Respiratory Medicine, State Key Laboratory of Respiratory Diseases, the First Affiliated Hospital of Guangzhou Medical University,